Reynders McVeigh Capital Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,055
| Closed | -$201K | – | 199 |
|
|
2024
Q1 | $201K | Buy |
+6,055
| New | +$201K | 0.01% | 194 |
|
|
2023
Q3 | – | Sell |
-10,996
| Closed | -$351K | – | 195 |
|
|
2023
Q2 | $351K | Sell |
10,996
-46,560
| -81% | -$1.49M | 0.02% | 165 |
|
|
2023
Q1 | $1.76M | Sell |
57,556
-12,227
| -18% | -$374K | 0.12% | 74 |
|
|
2022
Q4 | $2.73M | Sell |
69,783
-5,131
| -7% | -$201K | 0.2% | 64 |
|
|
2022
Q3 | $3.57M | Buy |
74,914
+7,039
| +10% | +$335K | 0.28% | 56 |
|
|
2022
Q2 | $2.63M | Sell |
67,875
-15,389
| -18% | -$596K | 0.2% | 61 |
|
|
2022
Q1 | $4.77M | Buy |
83,264
+4,136
| +5% | +$237K | 0.29% | 51 |
|
|
2021
Q4 | $6.31M | Buy |
79,128
+6,330
| +9% | +$504K | 0.36% | 46 |
|
|
2021
Q3 | $6.33M | Buy |
72,798
+1,693
| +2% | +$147K | 0.39% | 46 |
|
|
2021
Q2 | $9.15M | Buy |
71,105
+3,653
| +5% | +$470K | 0.56% | 44 |
|
|
2021
Q1 | $5.4M | Sell |
67,452
-1,237
| -2% | -$99K | 0.36% | 46 |
|
|
2020
Q4 | $5.61M | Buy |
68,689
+9,828
| +17% | +$802K | 0.38% | 45 |
|
|
2020
Q3 | $1.45M | Buy |
+58,861
| New | +$1.45M | 0.11% | 83 |
|